Mike Morin, a distinguished partner at Latham & Watkins LLP, has been recognized as a 2025 Law360 Intellectual Property MVP due to his exemplary work in high-stakes legal battles. Recently, Morin successfully navigated Sarepta Therapeutics to a $115 million victory in a patent dispute with Nippon Shinyaku Co. Ltd. His role was pivotal in securing a favorable outcome in this complex case, showcasing his strategic acumen and deep knowledge of intellectual property law.
In addition to his work with Sarepta, Morin notably led Abbott Laboratories’ unit to a win in another patent lawsuit, this time against Dexcom Inc. The intricacies of patent law, particularly in the pharmaceutical and medical device industries, require a meticulous approach to both legal strategy and technical detail. Morin’s success in these cases reflects his capability to master these challenges and deliver substantial results for his clients. More about his achievements can be found on Law360.
These achievements underscore the impact an experienced legal expert can have in navigating the often turbulent waters of intellectual property law. Morin’s career is marked by a series of high-profile victories that not only highlight his individual skills but also elevate the reputation of Latham & Watkins LLP as a leading firm in the field. His recognition as an MVP serves as a testament to the high regard in which he is held by peers and clients alike.